Trials / Completed
CompletedNCT02856204
Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia
Shotgun Sequencing for Etiologic Diagnosis of Febrile Neutropenia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 56 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research trial studies the shotgun sequencing of blood samples in diagnosing febrile neutropenia in patients with acute myeloid leukemia. Studying samples of blood from patients with acute myeloid leukemia in the laboratory may help identify pathogens and accurately diagnose infections such as febrile neutropenia.
Detailed description
PRIMARY OBJECTIVES: I. To test the hypothesis that shotgun metagenomics is not inferior to standard of care diagnostics in the detection of pathogens in patients with febrile neutropenia. SECONDARY OBJECTIVES: I. To establish a microbiological diagnosis with known or unknown pathogens in patients in whom standard care failed to yield a pathogenic diagnosis. OUTLINE: Patients undergo collection of blood samples before and during the episode of febrile neutropenia for up to 6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cytology Specimen Collection Procedure | Undergo collection of blood |
| OTHER | Laboratory Biomarker Analysis | Correlative studies |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2017-12-01
- Completion
- 2019-04-01
- First posted
- 2016-08-04
- Last updated
- 2019-05-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02856204. Inclusion in this directory is not an endorsement.